Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma
Crossref DOI link: https://doi.org/10.1007/s00280-016-2985-y
Published Online: 2016-02-20
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tanaka, Yoshihiro
Yoshida, Kazuhiro
Yamada, Atsuko
Tanahashi, Toshiyuki
Okumura, Naoki
Matsuhashi, Nobuhisa
Yamaguchi, Kazuya
Miyazaki, Tatsuhiko
License valid from 2016-02-20